GENE ONLINE|News &
Opinion
Blog

CAR-T Cell
Licensing Kite Pharma
Kite to Use Refuge’s Gene Expression Platform for New CAR-T Therapies
2022-10-21
Trials & Approvals European Commission
Kite’s Yescarta Climbs Up To Treat Second-Line B-Cell Lymphomas After EC Nod
2022-10-18
R&D CAR-T Cell
Overcoming Immune Evasion in CAR-T Therapies with Groundbreaking New Discoveries
2022-09-22
Partnerships Roche
Roche Dives Deeper into Off-The-Shelf Cell Therapies in Poseida Partnership
2022-08-04
Special Gene and Cell Therapy
Gene & Cell Therapy’s Big Leaps in the Past 5 Years
2022-07-08
Trials & Approvals CAR T-cell Therapy
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Trials & Approvals Johnson & Johnson
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Technology CAR T-cell Therapy
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Funding CAR T-cell Therapy
Boston’s Kelonia Therapeutics Bags $50M to Accelerate Genetic Medicines
2022-04-29
Innovation 2022 Single Cell Sequencing
Assembling the Aging Trajectory of Immune Cells with Single Cell Sequencing
2022-04-22
Feature AACR
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
Feature FDA
FDA Announces Draft Guidances on Genome Editing and CAR T Cell Therapy
2022-03-25
Trials & Approvals Bristol Myers Squibb
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
In-Depth ASH
ASH 2021: Engineering Stem Cells into Therapeutic Immune Cells
2021-12-21
Feature Blood CancerCancer Immunotherapy
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
1 2 3
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top